CRIS CANCER FOUNDATION

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +37.9%

  £2,036,264 → £2,807,184

• Cash

  +23.6%

  £2,260,864 → £2,794,083

• Net assets

  +26.2%

  £2,981,480 → £3,761,989

• Employees

  +66.7%

  3 → 5

• Wages

  +45.2%

  £110,480 → £160,397

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

UHY Hacker Young LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Charitable Company's ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue. The charity's policy is to maintain a sufficient level of reserves to enable the operating activities of the charity to continue. ... CRIS is accordingly in an enviable position as the risk of it not being able to operate as a going concern due to lack of funds is considered to be remote.”

Significant events

• “2024 has been another pivotal year for CRIS Cancer Foundation. This past year has been one of dedication, innovation, and real impact-driven by our shared mission to advance cancer research and improve lives.”
• “In 2024, CRIS achieved total incoming resources of £3,407,641, representing an 13% increase over 2023. Of this, £2,082,585 was invested directly in research-a 22% year-on-year increase.”
• “Our flagship event at the Natural History Museum in London was attended by approximately 400 guests in person, with additional supporters joining online. Parallel galas were held in Barcelona and Paris, bringing together supporters, researchers, and volunteers. ... the UK gala alone raised more than £2,800,000.”
• “At the year end, the charity is committed to make donation of £1,874,075 (2023: £558,328) to ICR and other Cancer projects through deeds of gifts.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.